glipizide has been researched along with Benign Cerebellar Neoplasms in 1 studies
Glipizide: An oral hypoglycemic agent which is rapidly absorbed and completely metabolized.
glipizide : An N-sulfonylurea that is glyburide in which the (5-chloro-2-methoxybenzoyl group is replaced by a (5-methylpyrazin-2-yl)carbonyl group. An oral hypoglycemic agent, it is used in the treatment of type 2 diabetes mellitus.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gontkovsky, ST | 1 |
| Nevels, R | 1 |
| McDonald, NB | 1 |
| Winkelmann, MH | 1 |
1 other study available for glipizide and Benign Cerebellar Neoplasms
| Article | Year |
|---|---|
Decreased serum glucose levels after initiation of methylphenidate in a patient status post-cerebellar tumour resection: a potential interaction with glipizide.
Topics: Adult; Blood Glucose; Central Nervous System Stimulants; Cerebellar Neoplasms; Cognition Disorders; | 2007 |